z-logo
open-access-imgOpen Access
Real-world clinical experience of extended half-life recombinant factor VIII Fc fusion protein (rFVIIIFc) in comparison to conventional factor products in patients with severe hemophilia A
Author(s) -
Johannes Oldenburg,
Georg Goldmann,
Natascha Marquardt,
Silvia Horneff,
Claudia Klein,
T. Albert,
Ruwan Perera
Publication year - 2021
Publication title -
journal of current medical research and opinion
Language(s) - English
Resource type - Journals
eISSN - 2589-8779
pISSN - 2589-8760
DOI - 10.15520/jcmro.v4i05.422
Subject(s) - medicine

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom